$70.00
SLU-PP-332 is a novel, synthetic small molecule acting as a pan-estrogen-related receptor (ERR) agonist. Highly regarded as a groundbreaking “exercise mimetic,” it is extensively researched for its profound ability to enhance mitochondrial biogenesis, aggressively upregulate fatty acid oxidation, and increase endurance capacity in skeletal muscle—all without the need for physical exertion in animal models.
SLU-PP-332 represents a major leap in metabolic and longevity research. It acts as an agonist for the estrogen-related receptor (ERR) family, specifically targeting ERRα, ERRβ, and ERRγ. These receptors play a central role in sensing cellular energy demands and orchestrating the body’s response to endurance exercise. In laboratory environments, SLU-PP-332 “tricks” the skeletal muscle into a state of high energy expenditure. Research demonstrates that administering this compound causes test subjects to metabolize fatty acids instead of glucose, effectively increasing the proportion of oxidative type IIa muscle fibers. It is a primary focus for studies addressing obesity, age-related sarcopenia, and metabolic decline where traditional exercise is impossible.
Technical Specifications
Mechanism of Action (Research Context)
Research into SLU-PP-332 focuses on its direct modulation of deep cellular energy grids:
Storage and Handling
Testing and Quality Control
At Flux Peptides, every batch of SLU-PP-332 undergoes:
Reviews
There are no reviews yet.